Cargando…

Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India

PURPOSE: For patients with COVID 19 severe ARDS, lung transplant offers the only hope, if appropriate criteria are met. METHODS: Retrospective analysis of 4 cases of bilateral lung transplant (LTx) at a private health facility between August to October 2020 RESULTS: All patients were male, with mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Jindal, A., Rao K G, S., K R, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979403/
http://dx.doi.org/10.1016/j.healun.2021.01.894
_version_ 1783667277307052032
author Jindal, A.
Rao K G, S.
K R, B.
author_facet Jindal, A.
Rao K G, S.
K R, B.
author_sort Jindal, A.
collection PubMed
description PURPOSE: For patients with COVID 19 severe ARDS, lung transplant offers the only hope, if appropriate criteria are met. METHODS: Retrospective analysis of 4 cases of bilateral lung transplant (LTx) at a private health facility between August to October 2020 RESULTS: All patients were male, with mean age of 52.1 years. The mean duration of ventilation before ECMO was 3 weeks. 3 patients had VV ECMO and one had a VA ECMO for circulatory collapse. This patient had previous coronary revascularization. The median duration on ECMO was 26 days. All patients were awake, involved in LTx discussion and actively rehabilitated. Profound myopathy was dominant in all. All had more than one episode of severe sepsis with Klebsiella pneumoniae and Acinetobacter requiring aggressive resuscitation and pressors. All had a trachestomy. Pneumothorax was treated with chest drains, 1 had hemothorax requiring thoracotomy. The lung was found to be extremely friable with dense adhesions in 3 with excessive chest wall bleeding. The ECMO was weaned off in all patients, 2 in the operating room and 2 in the ICU after 48 to 96 hours. The patient with CAD required VA ECMO due to transient left ventricular dysfunction. All patients could be weaned off the ventilator with excellent lung function breathing room air. The patient with CAD had Elizabeth meningoseptica septic shock in the late post op period with multi organ failure and death, while the other 3 are recovering and undergoing physical rehabilitation.Histology of the lungs showed alveolar damage, interstitial fibrosis with mononuclear infiltration, vasculitis and organizing fibrin thrombi, even in larger blood vessels. Electron microscopy showed absence of surfactant producing lamellar bodies in alveocytes, extensive mitochondrial damage and disrupted vascular endothelial lining with thrombus (Fig 1) CONCLUSION: Lung transplant is a viable option for selected patients of COVID-19 who do not recover lung function despite optimal medical care and have life threatening complications.
format Online
Article
Text
id pubmed-7979403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-79794032021-03-23 Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India Jindal, A. Rao K G, S. K R, B. J Heart Lung Transplant (779) PURPOSE: For patients with COVID 19 severe ARDS, lung transplant offers the only hope, if appropriate criteria are met. METHODS: Retrospective analysis of 4 cases of bilateral lung transplant (LTx) at a private health facility between August to October 2020 RESULTS: All patients were male, with mean age of 52.1 years. The mean duration of ventilation before ECMO was 3 weeks. 3 patients had VV ECMO and one had a VA ECMO for circulatory collapse. This patient had previous coronary revascularization. The median duration on ECMO was 26 days. All patients were awake, involved in LTx discussion and actively rehabilitated. Profound myopathy was dominant in all. All had more than one episode of severe sepsis with Klebsiella pneumoniae and Acinetobacter requiring aggressive resuscitation and pressors. All had a trachestomy. Pneumothorax was treated with chest drains, 1 had hemothorax requiring thoracotomy. The lung was found to be extremely friable with dense adhesions in 3 with excessive chest wall bleeding. The ECMO was weaned off in all patients, 2 in the operating room and 2 in the ICU after 48 to 96 hours. The patient with CAD required VA ECMO due to transient left ventricular dysfunction. All patients could be weaned off the ventilator with excellent lung function breathing room air. The patient with CAD had Elizabeth meningoseptica septic shock in the late post op period with multi organ failure and death, while the other 3 are recovering and undergoing physical rehabilitation.Histology of the lungs showed alveolar damage, interstitial fibrosis with mononuclear infiltration, vasculitis and organizing fibrin thrombi, even in larger blood vessels. Electron microscopy showed absence of surfactant producing lamellar bodies in alveocytes, extensive mitochondrial damage and disrupted vascular endothelial lining with thrombus (Fig 1) CONCLUSION: Lung transplant is a viable option for selected patients of COVID-19 who do not recover lung function despite optimal medical care and have life threatening complications. Published by Elsevier Inc. 2021-04 2021-03-20 /pmc/articles/PMC7979403/ http://dx.doi.org/10.1016/j.healun.2021.01.894 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle (779)
Jindal, A.
Rao K G, S.
K R, B.
Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title_full Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title_fullStr Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title_full_unstemmed Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title_short Case Series of Lung Transplants Done for COVID-19 Destroyed Lungs - Single Center Experience from India
title_sort case series of lung transplants done for covid-19 destroyed lungs - single center experience from india
topic (779)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979403/
http://dx.doi.org/10.1016/j.healun.2021.01.894
work_keys_str_mv AT jindala caseseriesoflungtransplantsdoneforcovid19destroyedlungssinglecenterexperiencefromindia
AT raokgs caseseriesoflungtransplantsdoneforcovid19destroyedlungssinglecenterexperiencefromindia
AT krb caseseriesoflungtransplantsdoneforcovid19destroyedlungssinglecenterexperiencefromindia